Business was a healthy 2.62 million admissions (in line with last year) over the frame as two big releases duked it out for the top spot. The local market share was down to 40%, well below last year's 60% but unsurprising given the big new release the past weekend.
||Pacific Rim (us)
||World War Z (us)
||Lone Ranger (us)
||The Adventures of Jinbao (ch)
||Side Effects (us)
||The Croods (us)
||The Master (us)
Leading the frame, though perhaps with a thinner margin than expected, was Guillermo del Toro's robots vs. monsters smash 'em up Pacific Rim. With 1,160,636 admission it fared a good deal better here than it did stateside. Its success does not come as a big surprise as Korea has demonstrated a keen appreciation of all things robot at the box office. Among the most successful films of all time here are Transformers 2 and Iron Man 3, while many other global hits have floundered. Will Korea's robot-philia keep Pacific Rim high on the charts? I imagine it will have some more strong business in store but it is unlikely to repeat at number one.
Cooling only 25% after a stellar debut was the Korea thriller Cold Eyes, starring Sol Kyung-gu, Jung Woo-sung and Han Hyo-joo. Reviews have been strong and clearly the word-of-mouth has kicked in, given it a healthy 1,003,049 admissions during its sophomore frame. Its total currently stands at 3.5 million and 5+ million finish seems assured.
Beginning its march out of theaters was the Brad Pitt zombie film World War Z, which drew another 345,896 spectators for a total that is about to eclipse 5 million. A very strong result.
Killer Toon lost half its business in week 3 for 107,173 but is now over the 1 million mark, a significant achievement for a K-horror.
Rounding out the Top 5 was Lone Ranger as it plummeted almost 85% in its second week for 34,668. A disastrous performance.
All eyes will be on the big-budget 3D baseball playing gorilla film Mr. Go this week. It's certainly to claim the top spot, but how far will it go?
Do you feel this content is inappropriate or infringes upon your rights? Click here
to report it, or see our DMCA policy